Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical modelsXiao Yu Wu, Liang Shen, Zhen Wu et al.|Oncotarget|2015Cited by 85
Effects of the combination of As<sub>2</sub>O<sub>3</sub> and AZT on proliferation inhibition and apoptosis induction of hepatoma HepG2 cells following silencing of Egr-1Chuan Zhao, Che Chen|OncoTargets and Therapy|2018Cited by 2